Metabolism of ginseng and its interactions with drugs

Current Drug Metabolism

Volumn 12, Issue 9, 2011, Pages 818-822

  Qi, Lian Wen ^a   Wang, Chong Zhi ^a   Du, Guang Jian ^a   Zhang, Zhi Yu ^a   Calway, Tyler ^a   Yuan, Chun Su ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Absorption; American ginseng; Asian ginseng; Compound K; Ginsenosides; Herb drug interaction; Metabolism; Metabolite; Panax ginseng; Panax quinquefolius

Indexed keywords

ANTINEOPLASTIC AGENT; COMPOUND K; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2B1; CYTOCHROME P450 2C9; CYTOCHROME P450 2D; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 3A23; CYTOCHROME P450 3A4; DRUG METABOLITE; GINSENG EXTRACT; GINSENG SAPONIN; GINSENOSIDE R 1; GINSENOSIDE RA 3; GINSENOSIDE RB 1; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 3; GINSENOSIDE RH 1; GINSENOSIDE RH 2; HERBACEOUS AGENT; INDINAVIR; PLACEBO; PROTOPANAXADIOL; PROTOPANAXATRIOL; UNCLASSIFIED DRUG; WARFARIN;

ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; DEGLYCOSYLATION; DRUG ABSORPTION; DRUG BILE LEVEL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG SOLUBILITY; GENE EXPRESSION; GINSENG; HERB DRUG INTERACTION; HUMAN; INTESTINE FLORA; LIVER MICROSOME METABOLISM; MEMBRANE PERMEABILITY; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBOCYTE AGGREGATION; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT OUTCOME;

EID: 80053535953     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920011797470128     Document Type: Review

References (65)

1. Qi, L.W.; Wang, C.Z.; Yuan, C.S. Isolation and analysis of ginseng: advances and challenges. Nat. Prod. Rep., 2011, 28(3), 467-495.
2. Christensen, L.P. Ginsenosides chemistry, biosynthesis, analysis and potential health effects Adv. Food Nutr. Res., 2009, 55, 1-99.
3. Yun, T.K. Panax ginseng-a non-organ-specific cancer preventive?. Lancet Oncol., 2001, 2(1), 49-55.
4. Qi, L.W.; Wang, C.Z.; Yuan, C.S. Ginsenosides from American ginseng: Chemical and pharmacological diversity. Phytochemistry, 2011, 72, 689-699.
5. Qi, L.W.; Wang, C.Z.; Yuan, C.S. American ginseng: Potential structure-function relationship in cancer chemoprevention. Biochem. Pharmacol., 2010, 80(7), 947-954.
6. Fuzzati, N. Analysis methods of ginsenosides J. Chromatogr. B, 2004, 812(1-2), 119-133. (Pubitemid 39535405)
7. Cho, S.H.; Chung, K.S.; Choi, J.H.; Kim, D.H.; Lee, K.T. Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cells. BMC Cancer, 2009, 9, 449-461.
8. Chae, S.; Kang, K.A.; Chang, W.Y.; Kim, M.J.; Lee, S.J.; Lee, Y.S.; Kim, H.S.; Kim, D.H.; Hyun, J.W. Effect of compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation in human lung cancer cells in vitro and in vivo. J. Agric. Food Chem., 2009, 57(13), 5777-5782.
9. Kim, D.Y.; Yuan, H.D.; Chung, I.K.; Chung, S.H. Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells. J. Agric. Food Chem., 2009, 57(4), 1532-1537.
10. Tawab, M.A.; Bahr, U.; Karas, M.; Wurglics, M.; Schubert-Zsilavecz, M., Drug Metab. Dispos., 2003, 31(8), 1065-1071.
11. Cai, Z.W.; Qian, T.X.; Wong, R.N.S.; Jiang, Z.H. Liquid chromatography-electrospray ionization mass spectrometry for metabolism and pharmacokinetic studies of ginsenoside Rg3. Anal. Chim. Acta, 2003, 492(1-2), 283-293. (Pubitemid 37101408)
12. Liu, H.F.; Yang, J.L.; Du, F.F.; Gao, X.M.; Ma, X.T.; Huang, Y.H.; Xu, F.; Niu, W.; Wang, F.Q.; Mao, Y.; Sun, Y.; Lu, T.; Liu, C.X.; Zhang, B.L.; Li, C. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab. Dispos., 2009, 37(12), 2290-2298.
13. Gu, Y.; Wang, G.J.; Sun, J.G.; Jia, Y.W.; Wang, W.; Xu, M.J.; Lv, T.; Zheng, Y.T.; Sai, Y. Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs. Food Chem. Toxicol., 2009, 47(9), 2257-2268.
14. Li, X.Y.; Wang, G.J.; Sun, H.G.; Hao, H.P.; Xiong, Y.Q.; Yan, B.; Zheng, Y.T.; Sheng, L.S. Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional chinese medicine (TCM) in rats. Biol. Pharm. Bull., 2007, 30(5), 847-851. (Pubitemid 46708624)
15. Wang, W.; Wang, G.J.; Xie, H.T.; Sun, J.G.; Zhao, S.; Jiang, X.L.; Li, H.; Lv, H.; Xu, M.J.; Wang, R. Determination of ginsenoside Rd in dog plasma by liquid chromatography-mass spectrometry after solid-phase extraction and its application in dog pharmacokinetics studies. J. Chromatogr. B, 2007, 852(1-2), 8-14. (Pubitemid 46839207)
16. Xie, H.T.; Wang, G.J.; Sun, J.G.; Tucker, I.; Zhao, X.C.; Xie, Y.Y.; Li, H.; Jiang, X.L.; Wang, R.; Xu, M.J.; Wang, W. High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies. J. Chromatogr. B, 2005, 818(2), 167-173. (Pubitemid 40331821)
17. Qian, T.; Cai, Z.; Wong, R.N.; Jiang, Z.H. Liquid chromatography/mass spectrometric analysis of rat samples for in vivo metabolism and pharmacokinetic studies of ginsenoside Rh2. Rapid Commun. Mass Spectrom., 2005, 19(23), 3549-3554. (Pubitemid 41691930)
18. Sun, J.; Wang, G.; Haitang, X.; Hao, L.; Guoyu, P.; Tucker, I. Simultaneous rapid quantification of ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol in rat plasma by liquid chromatography-mass spectrometry after solidphase extraction. J. Pharm. Biomed. Anal., 2005, 38(1), 126-132. (Pubitemid 40725098)
19. Joo, K.M.; Lee, J.H.; Jeon, H.Y.; Park, C.W.; Hong, D.K.; Jeong, H.J.; Lee, S.J.; Lee, S.Y.; Lim, K.M. Pharmacokinetic study of ginsenoside Re with pure ginsenoside Re and ginseng berry extracts in mouse using ultra performance liquid chromatography/mass spectrometric method. J. Pharm. Biomed. Anal., 2010, 51(1), 278-283.
20. Lai, L.; Hao, H.P.; Liu, Y.T.; Zheng, C.N.; Wang, Q.; Wang, G.J.; Chen, X.J. Characterization of Pharmacokinetic Profiles and Metabolic Pathways of 20(S)-Ginsenoside Rh1 in vivo and in vitro. Planta Med., 2009, 75(8), 797-802.
21. Xu, Q.F.; Fang, X.L.; Chen, D.F. Pharmacokinetics and bioavailability of ginsenoside Rb-1 and Rg(1) from Panax notoginseng in rats. J. Ethnopharmacol., 2003, 84(2-3), 187-192. (Pubitemid 36324258)
22. Paek, I.P.; Moon, Y.; Kim, J.; Ji, H.Y.; Kim, S.A.; Sohn, D.H.; Kim, J.B.; Lee, H.S. Pharmacokinetics of a ginseng saponin metabolite compound K in rats. Biopharm. Drug Dispos., 2006, 27(1), 39-45. (Pubitemid 43173973)
23. Li, L.; Sheng, Y.X.; Zhang, J.L.; Wang, S.S.; Guo, D.A. Highperformance liquid chromatographic assay for the active saponins from Panax notoginseng in rat tissues. Biomed. Chromatogr., 2006, 20(4), 327-335.
24. Gui, F.J.; Yang, X.W.; Li, L.Y.; Tian, J.M. Simultaneous enantiomer determination of 20 (R)- and 20 (S)-ginsenoside-Rg(2) in rat plasma after intravenous administration using HPLC method. J. Chromatogr. B, 2007, 850(1-2), 1-6.
25. Chen, S.E.; Sawchuk, R.J.; Staba, E.J. American ginseng. III. Pharmacokinetics of ginsenosides in the rabbit. Eur. J. Drug Metab. Pharmacokinet., 1980, 5(3), 161-168. (Pubitemid 11252888)
26. Hasegawa, H. Proof of the mysterious efficacy of ginseng: Basic and clinical trials: Metabolic activation of ginsenoside: Deglycosylation by intestinal bacteria and esterification with fatty acid. J. Pharmacol. Sci., 2004, 95(2), 153-157. (Pubitemid 38899683)
27. Lee, P.S.; Song, T.W.; Sung, J.H.; Moon, D.C.; Song, S.; Chung, Y.B. Pharmacokinetic characteristics and hepatic distribution of IH-901, a novel intestinal metabolite of ginseng saponin, in rats. Planta Med., 2006, 72(3), 204-210.
28. Hao, H.; Lai, L.; Zheng, C.; Wang, Q.; Yu, G.; Zhou, X.; Wu, L.; Gong, P.; Wang, G. Microsomal cytochrome p450-mediated metabolism of protopanaxatriol ginsenosides: metabolite profile, reaction phenotyping, and structure-metabolism relationship. Drug Metab. Dispos., 2010, 38(10), 1731-1739.
29. Cui, J.F.; Bjorkhem, I.; Eneroth, P. Gas chromatographic-mass spectrometric determination of 20(S)-protopanaxadiol and 20(S)- protopanaxatriol for study on human urinary excretion of ginsenosides after ingestion of ginseng preparations. J. Chromatogr. B, 1997, 689(2), 349-355. (Pubitemid 27091361)
30. Lee, J.; Lee, E.; Kim, D.; Lee, J.; Yoo, J.; Koh, B. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J. Ethnopharmacol., 2009, 122(1), 143-148.
31. Hasegawa, H.; Sung, J.H.; Matsumiya, S.; Uchiyama, M. Main Ginseng saponin metabolites formed by intestinal bacteria. Planta Med., 1996, 62(5), 453-457. (Pubitemid 26370341)
32. Kong, H.; Wang, M.; Venema, K.; Maathuis, A.; van der Heijden, R.; van der Greef, J.; Xu, G.; Hankemeier, T. Bioconversion of red ginseng saponins in the gastro-intestinal tract in vitro model studied by high-performance liquid chromatography-high resolution Fourier transform ion cyclotron resonance mass spectrometry. J. Chromatogr. A, 2009, 1216(11), 2195-2203.
33. Ruan, J.Q.; Leong, W.I.; Yan, R.; Wang, Y.T. Characterization of metabolism and in vitro permeability study of notoginsenoside R1 from Radix notoginseng. J. Agric. Food Chem., 2010, 58, (9), 5770-5776.
34. Qiang, T.X.; Jiang, Z.H.; Cai, Z.W. High-performance liquid chromatography coupled with tandem mass spectrometry applied for metabolic study of ginsenoside Rb, on rat.. Anal. Biochem., 2006, 352(1), 87-96.
35. Yang, L.; Deng, Y.H.; Xu, S.J.; Zeng, X. In vivo pharmacokinetic and metabolism studies of ginsenoside Rd. J. Chromatogr. B, 2007, 854(1-2), 77-84. (Pubitemid 46962368)
36. Bae, E.A.; Han, M.J.; Choo, M.K.; Park, S.Y.; Kim, D.H. Metabolism of 20(S)- and 20(R)-ginsenoside R-g3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull., 2002, 25(1), 58-63.
37. Shin, Y.W.; Bae, E.A.; Kim, D.H. Inhibitory effect of ginsenoside Rg5 and its metabolite ginsenoside Rh3 in an oxazolone-induced mouse chronic dermatitis model. Arch. Pharm. Res., 2006, 29(8), 685-690.
38. Wang, Y.; Wang, B.X.; Liu, T.H.; Minami, M.; Nagata, T.; Ikejima, T. Metabolism of ginsenoside Rg(1) by intestinal bacteria II. Immunological activity of ginsenoside Rg(1) and Rh-1. Acta Pharmacol. Sin., 2000, 21(9), 792-796.
39. Yang, L.; Xu, S.J.; Liu, C.J.; Su, Z.J. In vivo metabolism study of ginsenoside Re in rat using high-performance liquid chromatography coupled with tandem mass spectrometry. Anal. Bioanal. Chem., 2009, 395(5), 1441-1451.
40. Lee, S.J.; Ko, W.G.; Kim, J.H.; Sung, J.H.; Lee, S.J.; Moon, C.K.; Lee, B.H. Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. Biochem. Pharmacol., 2000, 60(5), 677-685.
41. Kang, K.A.; Kim, Y.W.; Kim, S.U.; Chae, S.; Koh, Y.S.; Kim, H.S.; Choo, M.K.; Kim, D.H.; Hyun, J.W. G1 phase arrest of the cell cycle by a ginseng metabolite, compound K, in U937 human monocytic leukamia cells. Arch. Pharm. Res., 2005, 28(6), 685-690. (Pubitemid 43073635)
42. Jung, S.H.; Woo, M.S.; Kim, S.Y.; Kim, W.K.; Hyun, J.W.; Kim, E.J.; Kim, D.H.; Kim, H.S. Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells. Int. J. Cancer, 2006, 118(2), 490-497.
43. Choi, K.; Kim, M.; Ryu, J.; Choi, C. Ginsenosides compound K and Rh-2 inhibit tumor necrosis factor-alpha-induced activation of the NF-kappa B and JNK pathways in human astroglial cells. Neurosci. Lett., 2007, 421(1), 37-41. (Pubitemid 46899328)
44. Oh, S.H.; Lee, B.H. A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage. Toxicol. Appl. Pharm., 2004, 194(3), 221-229.
45. Oh, S.H.; Yin, H.Q.; Lee, B.H. Role of the Fas/Fas ligand death receptor pathway in ginseng saponin metabolite-induced apoptosis in HepG2 cells. Arch. Pharm. Res., 2004, 27(4), 402-406.
46. Surh, Y.J.; Lee, J.Y.; Choi, K.J.; Ko, S.R. Effects of selected ginsenosides on phorbol ester-induced expression of cyclooxygenase- 2 and activation of NF-kappa B and ERK1/2 in mouse skin. Ann. Ny. Acad. Sci., 2002, 973, 396-401.
47. Yu, C.T.; Chen, J.; Teng, X.W.; Tong, V.; Chang, T.K.H. Lack of evidence for induction of CYP2B1, CYP3A23, and CYP1A2 gene expression by Panax ginseng and Panax quinquefolius extracts in adult rats and primary cultures of rat hepatocytes. Drug Metab. Dispos., 2005, 33(1), 19-22. (Pubitemid 40023509)
48. Gurley, B.J.; Gardner, S.F.; Hubbard, M.A.; Williams, D.K.; Gentry, W.B.; Cui, Y.; Ang, C.Y.W. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin. Pharmacol. Ther., 2002, 72(3), 276-287.
49. Gurley, B.J.; Gardner, S.F.; Hubbard, M.A.; Williams, D.K.; Gentry, W.B.; Cui, Y.Y.; Ang, C.Y.W. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly - St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drug Aging, 2005, 22(6), 525-539. (Pubitemid 41003065)
50. Liu, Y.; Zhang, J.W.; Li, W.; Ma, H.; Sun, J.; Deng, M.C.; Yang, L. Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes. Toxicol. Sci., 2006, 91(2), 356-364. (Pubitemid 43827288)
51. Andrade, A.S.A.; Hendrix, C.; Parsons, T.L.; Caballero, B.; Yuan, C.S.; Flexner, C.W.; Dobs, A.S.; Brown, T.T. Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir. BMC Complement. Altern. Med., 2008, 8(50), 1-10.
52. Zhu, M.; Chan, K.W.; Ng, L.S.; Chang, Q.; Chang, S.; Li, R.C. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J. Pharm. Pharmacol., 1999, 51(2), 175-180. (Pubitemid 29131310)
53. Janetzky, K.; Morreale, A.P. Probable interaction between warfarin and ginseng. Am. J. Health Syst. Pharm., 1997, 54(6), 692-693. (Pubitemid 27136670)
54. Yuan, C.S.; Wei, G.; Dey, L.; Karrison, T.; Nahlik, L.; Maleckar, S.; Kasza, K.; Ang-Lee, M.; Moss, J. Brief communication: American ginseng reduces warfarin's effect in healthy patients: A randomized, controlled trial. Ann. Int. Med., 2004,141, 23-27
55. Pascussi, J.M.; Gerbal-Chaloin, S.; Fabre, J.M.; Maurel, P.; Vilarem, M.J. Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: Consequences on cytochrome P450 gene regulation. Mol. Pharmacol., 2000, 58(6), 1441-1450.
56. Lee, S.H.; Ahn, Y.M.; Ahn, Y.M.; Doo, H.K.; Lee, B.C. Interaction between warfarin and Panax ginseng in ischemic stroke patients. J. Altern. Complement. Med. 2008, 14(6), 715-721.
57. Lee, Y.H.; Lee, B.K.; Choi, Y.J.; Yoon, I.K.; Chang, B.C.; Gwak, H.S. Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement. Int. J. Cardiol., 2010, 145(2), 275-276.
58. Kuo, S.C.; Teng, C.M.; Lee, J.C.; Ko, F.N.; Chen, S.C.; Wu, T.S. Antiplatelet components in Panax-Ginseng, Planta Med., 1990, 56(2), 164-167.
59. Park, H.J.; Lee, J.H.; Song, Y.B.; Park, K.H. Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation. Biol. Pharm. Bull., 1996, 19(11), 1434-1439.
60. Teng, C.M.; Kuo, S.C.; Ko, F.N.; Lee, J.C.; Lee, L.G.; Chen, S.C.; Huang, T.F. Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng, Biochim. Biophys. Acta, 1989, 990(3), 315-320.
61. Lee, J.G.; Lee, Y.Y.; Kim, S.Y.; Pyo, J.S.; Yun-Choi, H.S.; Park, J.H. Platelet antiaggregating activity of ginsenosides isolated from processed ginseng. Pharmazie, 2009, 64(9), 602-604.
62. Lee, J.G.; Lee, Y.Y.; Wu, B.; Kim, S.Y.; Lee, Y.J.; Yun-Choi, H.S.; Park, J.H. Inhibitory activity of ginsenosides isolated from processed ginseng on platelet aggregation. Pharmazie, 2010, 65(7), 520-522.
63. Ang-Lee, M.K.; Moss, J.; Yuan, C.S. Herbal medicines and perioperative care. JAMA, 2001, 286(2), 208-216. (Pubitemid 32640852)
64. Lim, W.; Mudge, K.W.; Vermeylen, F. Effects of population, age, and cultivation methods on ginsenoside content of wild American ginseng (Panax quinquefolium). J. Agric. Food Chem., 2005, 53(22), 8498-8505. (Pubitemid 41608905)
65. Lin, W.N.; Lu, H.Y.; Lee, M.S.; Yang, S.Y.; Chen, H.J.; Chang, Y.S.; Chang, W.T. Evaluation of the cultivation age of dried ginseng radix and its commercial products by using (1)H-NMR fingerprint analysis. Am. J. Chin. Med., 2010, 38(1), 205-218.